
Regulatory Due Diligence for Buying Licensed Company
- NUR Legal

- 3 days ago
- 5 min read
A licensed company can look like a shortcut until you inherit its regulator history, weak controls, and banking exposure. That is why regulatory due diligence for buying licensed company assets is not a box-ticking exercise. In crypto, fintech, payments, forex, and iGaming, the licence is only part of the value. The real question is whether the entity can operate safely, pass ongoing supervision, and support your commercial plan without triggering expensive remediation.
For acquisition-led founders and operators, speed matters. So does certainty. Buying an existing regulated vehicle can cut months from market entry, but only if the target stands up to close legal and compliance review. If it does not, the purchase price can quickly become secondary to the cost of fixing governance, replacing providers, re-papering policies, or defending the business before the regulator.
What regulatory due diligence for buying licensed company really means
In regulated sectors, standard corporate due diligence is not enough. You are not just buying shares, contracts, or a customer base. You are stepping into a live relationship with a regulator, and that relationship comes with history. Supervisory findings, reporting failures, weak AML controls, outsourced compliance gaps, and undisclosed beneficial ownership issues do not disappear at completion.
A proper review tests whether the licence is valid, usable, and aligned with your intended model. An EMI licence, VASP registration, gaming permit, or PSP authorisation may look transferable in commercial terms but become far less useful if the approved activities are too narrow, the regulator expects prior approval for change of control, or key function holders must be replaced before you can scale.
This is where many buyers get caught out. They assess the existence of a licence, but not the quality of the regulatory perimeter around it.
Start with the licence, but do not stop there
The first layer is obvious. Confirm the exact licence or registration held, the issuing authority, the scope of approved activities, territorial limitations, passporting position where relevant, and any conditions attached to the authorisation. Ask whether the target is fully operational, inactive, restricted, or under any form of enhanced monitoring.
Then go deeper. Review all regulator correspondence for at least the last three years, and longer if the jurisdiction or business line justifies it. Formal notices matter, but informal supervisory pressure matters too. A business may tell you there are no sanctions while omitting repeated remediation demands, delayed responses, or unresolved findings from inspections.
You also need to understand whether the seller's current model matches the licensed one. If the company has been operating outside scope, that is not a technicality. It can affect the durability of the licence after acquisition and may force a post-closing restructuring before the business can trade as planned.
AML, compliance, and governance are where value is won or lost
For most buyers, the highest-risk area is not the corporate shell but the control framework. Weak AML and compliance architecture can damage banking access, investor confidence, and regulator trust well after closing.
Review the AML and KYC programme as it exists in practice, not only on paper. Policies should be current, jurisdiction-specific, and consistent with actual onboarding, monitoring, escalation, screening, and reporting processes. Check how risk assessments are documented, how suspicious activity is handled, whether sanctions controls are calibrated properly, and whether outsourced providers are supervised in any meaningful way.
Governance deserves the same attention. Who are the approved directors, MLRO, compliance officer, local managers, and ultimate beneficial owners? Are they still in place? Are they resident where required? Have they been accepted by the regulator for those roles, and will your acquisition trigger fit and proper reassessment? In many transactions, the deal timetable is driven less by share transfer mechanics and more by regulatory approval of new controllers and officers.
A licensed entity with impressive paperwork but no operational governance discipline is not a ready platform. It is a remediation project.
Banking, payments, and counterparties can be a hidden deal-breaker
A licensed company without stable banking is often less valuable than an unlicensed company with a credible route to licensing. This is particularly true in crypto, payments, and higher-risk iGaming structures.
Due diligence should test whether bank accounts are active, fully usable, and aligned with the target business. Confirm who the banking partners are, what products are available, whether any restrictions apply, and whether account continuity is expected after change of control. Some institutions will require a full re-underwriting of the customer relationship once ownership changes. Others may quietly offboard the entity after completion if the new shareholder profile, jurisdictions served, or transaction flows no longer fit their risk appetite.
The same logic applies to payment providers, card acquirers, software vendors, game aggregators, liquidity providers, and critical compliance vendors. A licence may survive a transaction while the operating stack does not. If key contracts terminate on change of control, or if counterparties reserve broad discretion to reassess risk, your speed-to-market assumptions can collapse quickly.
Regulatory due diligence for buying licensed company in cross-border structures
Cross-border targets require extra caution because the corporate map often looks cleaner than the regulatory reality. A holding company in one jurisdiction, licensed subsidiary in another, outsourced compliance in a third, and customer flows touching multiple regions can create significant exposure.
You need to identify which legal entity actually holds the authorisation, where mind and management sit, where staff perform regulated functions, and whether outsourcing arrangements satisfy local rules. Tax and substance should be reviewed alongside regulation, but not treated as a substitute for it. A structure may be tax-efficient and still fail basic supervisory expectations on local presence, governance, or control.
This issue is increasingly relevant under modern EU-facing frameworks. Businesses selling into Europe, preparing for MiCA-aligned operations, or relying on digital resilience arrangements under DORA need more than nominal licensing. They need an entity that can withstand regulator scrutiny on systems, incident management, outsourcing, and board oversight.
Red flags that justify repricing or walking away
Some defects can be fixed after completion. Others signal that the transaction should be repriced, delayed, or abandoned.
Recurring red flags include unresolved regulator findings, stale AML documentation, unexplained account closures, nominee-heavy ownership histories, unapproved business model changes, poor record-keeping, and over-reliance on one local service provider who effectively controls the regulated entity. Another common issue is licence mismatch: the target technically holds an authorisation, but not one that supports your intended products, client base, or geography.
There is also the seller conduct question. If key compliance documents appear only late in the process, management answers are inconsistent, or regulator correspondence is summarised rather than produced, assume the risk is higher than presented. In regulated acquisitions, transparency is itself a quality signal.
How buyers should run the process
The best transactions are handled in workstreams, not as one general legal review. Corporate, regulatory, AML, data protection, commercial contracts, employment, and technology all need to be examined, but regulatory findings should lead the sequencing. If the licence position is weak, there is little value in spending weeks polishing ancillary points.
A buyer should also plan early for regulator engagement. In many jurisdictions, pre-transaction contact with the authority or at least a carefully structured notification strategy is commercially sensible. It helps test timing, approval expectations, local substance requirements, and likely questions around new ownership, source of funds, and business plan changes.
Where the goal is speed, a ready-made regulated vehicle can still be the right route. But the point of buying one is not simply to acquire a certificate. It is to acquire a lawful operating platform with a realistic path to onboarding clients, maintaining banking, and expanding without immediate remediation. That distinction is where sophisticated buyers save time and avoid false economies.
At NUR Legal, this is usually where buyers benefit from specialist support. A transaction in a regulated market needs more than legal confirmation that the company exists and the shares can be transferred. It needs a clear decision on whether the licence is usable, what approvals are needed, what must be fixed, and how fast the business can actually go live.
The smartest acquirers treat due diligence as a go-live test, not a paperwork exercise. If the target cannot satisfy that test, buying faster may simply mean failing sooner.



Comments